The PI3K/AKT/mTOR pathway is highly dysregulated in ccRCC [4]; targeting mTOR (which modulates cellular survival, blood vessel development, and nutrients) with rapamycin can modulate LD formation [5]. This evidence concerns the gene AKT1 and nonpapillary renal cell carcinoma.